Understand the source comparison
Peptides for Libido: Head-to-Head Comparison
No single resource in the current search landscape compares these peptides against each other. The table below covers mechanism, evidence, suitability, and practical considerations. Mechanism MC4R: dopamine + oxytocin HPG axis + direct neural MC1R-MC5R (non-se
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- No single resource in the current search landscape compares these peptides against each other. The table below covers mechanism, evidence, suitability, and practical considerations.
- Mechanism
- MC4R: dopamine + oxytocin
- HPG axis + direct neural
- MC1R-MC5R (non-selective)
- Amygdala GABA modulation
- GnRH: LH/FSH: T/E2
- FDA approved
- Yes (Vyleesi, women HSDD)
- No
- No (diagnostic only)
- Evidence level
- Phase III RCT (n=1,247)
- Phase II RCT (n=32+32)
- Phase II (small studies)
- Mixed (inconclusive)
- Indirect
- Works for women
- Yes (approved indication)
- Yes (clinical data)
- Yes (limited data)
- Mixed
- Indirect only
- Works for men
- Yes (off-label)
- Yes (strong data)
- Weak evidence
- Onset
- 45 min to 2 hours
- 15 to 60 min (hormonal)
- Hours (loading days)
- Minutes (intranasal)
- 1 to 2 months
- Duration
- 6 to 24 hours
- Minutes to hours
- Days to weeks (with loading)
- Hours
- Ongoing
- Key side effect
- Nausea (40%)
- Minimal
- Nausea + skin darkening
- Nasal irritation
- Unique benefit
- Only FDA-approved option
- Natural HPG activation
- Tanning + libido combo
- Bonding enhancement
- Preserves fertility on TRT
- Difficulty
- Beginner
- Advanced
- Intermediate
- Price
- $$
- $$$
- $